📰 Central Licensing News
Central Licensing News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Central Licensing. Real-time updates on events, politics, business and more.
January 13, 2024
Of the 19 FDCs, in June, the Union government — on orders of the drug regulatory agency Central Drugs Standard Control Organisation (CDSCO) --- announced the ban on 14 FDCs after they were found to lack therapeutic relevance
April 5, 2023
The Ministry of Labour has requested information from ministries and deputy-ministries on contracting out security and cleaning services at a lower cost.And this because it wants to see if the services are within the framework of the implementation of the National Minimum Wage law – in effect as fro
June 28, 2022
A Bala restaurant which features traditional Portuguese food has been licensed to sell drinks and play recorded and live music, with conditions.
December 16, 2021
The Lagos Division of the Federal High Court did not declare as illegal or invalid marriages conducted at the Federal Marriage Registry in Ikoyi, Lagos, PREMIUM TIMES reports. Justice D.E Osiagor in his judgment on December 8, obtained by PREMIUM TIMES, granted an order restraining the Ministry of Interior from further contracting, celebrating, or registering…
December 15, 2021
The judge did not also declare the closure of the Federal Marriage Registry in Ikoyi, Lagos, "with immediate effect.........."
October 30, 2021
The company aims to develop a cutting-edge and affordable treatment option for COVID-19 and neutralise the disease in minimum treatment duration
January 8, 2021
Text Size: A+ The year 2021 in India began with a flurry of events around the Covid-19 vaccine. The Indian government conducted dry runs for the vaccines, and two vaccines Covishield (Oxford University-AstraZeneca) and Covaxin (Bharat Biotech) were granted accelerated regulatory approval by the Central Drugs Standard Control Organisation (CDSCO). The process of granting these vaccines regulatory approval has been a subject of intense scrutiny. The grant of these approvals and the scrutiny ...
January 3, 2021
Bharat Biotech obtains Central Licensing Authoritys permission to manufacture and sell COVAXIN The firm will have to submit safety data with due analysis every 15 days for 2 months and monthly thereafter. January 04, 2021 / 07:12 AM IST The Central Licensing authority has issued permission to Bharat Biotech to manufacture pharmaceutical formulation of a new drug-- COVAXIN for sale or distribution on January 3. The firm will have to submit safety data with due analysis every 15 days for 2 mo...